Influenza A pandemic (H1N1) 2009 virus continues to rapidly spread worldwide. In 2009, pandemic (H1N1) 2009 infection in a domestic cat from Iowa was diagnosed by a novel PCR assay that distinguishes between Eurasian and North American pandemic (H1N1) 2009 virus matrix genes. Human-to-cat transmission is presumed.
Influenza viruses are typically host specific; aquatic birds are considered the primary reservoir. However, interspecies transmission does occur (
A 13-year-old, castrated male
At the time of examination, the cat had bilateral adventitial lung sounds (wheezes), was afebrile, and was clinically dehydrated. Radiographs of the thorax showed a bilateral caudodorsal alveolar pattern (
Radiographs of the thorax of a cat with confirmed influenza A pandemic (H1N1) 2009 virus infection. A) Right lateral view; B) dorsoventral view. Asymmetric soft tissue opacities are evident in the right and left caudal lung lobes. An alveolar pattern, composed of air bronchograms with border-effaced (indistinct) adjacent pulmonary vessels, is most pronounced in the left caudal lobe. A small gas lucency in the pleural space appears in the right caudal and dorsal thoracic cavity. An endotracheal tube is visible at the thoracic inlet on the lateral view in this moderately obese cat. L, left.
PCR testing (Feline URD Panel; Idexx Laboratories, Westbrook, ME, USA) of a BAL sample showed negative results for
RNA was obtained from the BAL fluid by using the MagMAX Viral RNA Isolation Kit (Applied Biosystems, Austin, TX, USA) and a semiautomated magnetic particle processor (Kingfisher 96; Thermo Electron Corp., Woodstock, GA, USA) according to manufacturer’s recommendations. Molecular testing used a real-time reverse transcription–PCR (rRT-PCR) influenza A screening assay specific for the nucleoprotein gene. Preliminary differentiation of pandemic (H1N1) 2009 virus from other H1 or H3 types of influenza A was performed by using an in-house rRT-PCR assay that distinguishes between pandemic (H1N1) 2009 [Eurasian matrix (
| Name | Sequence (5′ → 3′) | Description |
|---|---|---|
| Influenza A NP screening assay | ||
| SIVRTF | CGGACGAAAAGGCAACGA | NP forward primer |
| SIVRTR | CTGCATTGTCTCCGAAGAAATAAG | NP reverse primer |
| SIVRTP | CCGATCGTGCCYTC | NP probe, MGB FAM |
| Pandemic influenza M differentiation assay | ||
| M_F | TCAGGCCCCCTCAAAGC | M forward primer |
| M_R1 | CATTCCATGAGAGCCTCAAGATC | M reverse primer 1 |
| M_R1a | CACTCCATGAGAGCCTCAAGATC | M reverse primer 2 |
| M_R1b | CATTCCATGAGTGCCTCAAGATC | M reverse primer 3 |
| M_EUPr | CAGAGACTGGAAAGTGT | EU M MGB, VIC |
| M_NAPr | CAGAGACTYGAAGAYGT | NA M MGB, FAM |
*Primers and MGB probes were obtained from Integrated DNA Technologies (Coralville, IA, USA) and Applied Biosystems Inc. (Foster City, CA, USA), respectively. SIV, swine influenza virus; NP, nucleoprotein; M, matrix.
PCR testing showed the BAL sample to be positive for influenza A virus (nucleoprotein gene), and the virus was determined to contain the matrix (M) gene of the pandemic (H1N1) 2009 virus strain. A BAL sample was submitted to the US Department of Agriculture National Veterinary Services Laboratories (Ames, IA, USA) for confirmatory testing. rRT-PCR confirmed that the BAL sample was positive for the M gene of influenza A virus and the neuraminidase (N) gene of pandemic (H1N1) 2009 virus. Sequences of primers and probes are summarized in
| Name | Sequence (5′ → 3′) | Description |
|---|---|---|
| Influenza A M screening assay | ||
| M+25 | AGATGAGTCTTCTAACCGAGGTCG | AI M forward primer |
| M-124 | TGCAAAAACATCTTCAAGTCTCTG | AI M reverse primer |
| M-124siv | TGCAAAGACACTTTCCAGTCTCTG | H1N1 M reverse primer |
| M+64 | TCAGGCCCCCTCAAAGCCGA | M probe, BHQ, FAM |
|---|---|---|
| Pandemic influenza N1 differentiation assay | ||
| N1 220F | CAACACCAACTTTGCTGC | N1 forward primer |
| N1 330R | GGAACCGATTCTTACACTGTTGTC | N1 reverse primer |
| N1 232 | CAGTCAGTGGTTTCCGTGAAATTAGC | N1 BHQ, FAM |
*Primers and probes were obtained from Integrated DNA Technologies (Coralville, IA, USA) and Biosearch Technologies, Inc. (Novato, CA, USA), respectively. M, matrix; AI, avian influenza; N, neuraminidase.
The cat was discharged from the medical center after diagnostic testing and correction of dehydration. A veterinarian (B.A.S.) visited the home to monitor the cat’s clinical status and administer subcutaneous fluids (120–160 mL) until the cat’s appetite improved; adventitial lung sounds resolved within 3 days. Reassessment 1 week later showed marked improvement of clinical signs but only modest improvement of the lymphopenia and radiographic findings.
Because the cat was from a single-animal household and remained indoors, he was presumably infected through contact with the family members. Attempts to retrospectively confirm pandemic (H1N1) 2009 infection in the family members have been unsuccessful, but additional testing of archived biologic samples is being conducted. Although more surveillance and studies are needed to determine susceptibility of companion animals to the pandemic (H1N1) 2009 virus, possible reverse zoonotic transmission (humans to animals) remains a concern. Indeed, cases in a domestic dog and other felids have been confirmed (
We thank the family members in the cat’s household for their cooperation and Sarah Abate, Wendy Stensland, and Leslie Bower for technical assistance.
This study was supported by the Iowa State University Office of the Vice President for Research and Economic Development, the Iowa Healthy Livestock Initiative Research Grant, and the Center for Advanced Host Defenses, Immunobiotics and Translational Comparative Medicine.
Dr Sponseller is an assistant professor in the Departments of Veterinary Clinical Sciences and Veterinary Microbiology and Preventive Medicine, College of Veterinary Medicine, Iowa State University. His research focuses on viral pathogens of domestic animals and acquisition of pulmonary immunocompetency.